Quantification of increased biologically active CXCL12α plasma concentrations after ACKR3 antagonist treatment in humans di Peter Blattmann, Hervé Farine, Brian Dan, Nicole Stiffler, Thomas Lefebvre, Christine Huynh, Patricia N. Sidharta, Jasper Dingemanse, Richard W. D. Welford, Marcel Keller, Daniel S. Strasser

Testo